These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
706 related items for PubMed ID: 15701853
1. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. An C, Choi IS, Yao JC, Worah S, Xie K, Mansfield PF, Ajani JA, Rashid A, Hamilton SR, Wu TT. Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):656-63. PubMed ID: 15701853 [Abstract] [Full Text] [Related]
3. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, Juhng SW, Rashid A, Hamilton SR, Wu TT. Oncogene; 2004 Jun 03; 23(26):4646-54. PubMed ID: 15064707 [Abstract] [Full Text] [Related]
4. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer. Shigeyasu K, Nagasaka T, Mori Y, Yokomichi N, Kawai T, Fuji T, Kimura K, Umeda Y, Kagawa S, Goel A, Fujiwara T. PLoS One; 2015 Jun 03; 10(6):e0130409. PubMed ID: 26121593 [Abstract] [Full Text] [Related]
9. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K. Int J Cancer; 1999 Oct 29; 83(3):309-13. PubMed ID: 10495421 [Abstract] [Full Text] [Related]
10. [Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability]. Li JH, Shi XZ, Liu M, Wang Y, Yu ZH, Xu GW, Lu S. Ai Zheng; 2005 Mar 29; 24(3):273-7. PubMed ID: 15757526 [Abstract] [Full Text] [Related]
13. High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer. Chen HY, Zhu BH, Zhang CH, Yang DJ, Peng JJ, Chen JH, Liu FK, He YL. Cancer Sci; 2012 Jan 15; 103(1):73-9. PubMed ID: 22017425 [Abstract] [Full Text] [Related]
14. Microsatellite instability in gastric cancer is closely associated with hMLH1 hypermethylation at the proximal region of the promoter. Ishiguro K, Kawakami K, Maeda K, Ishida Y, Omura K, Watanabe G. Int J Mol Med; 2003 Oct 15; 12(4):603-8. PubMed ID: 12964042 [Abstract] [Full Text] [Related]
15. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. Levine AJ, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen SA, Lindor NM, Newcomb PA, Rosty C, Haile RW, Laird PW, Weisenberger DJ. Cancer Epidemiol Biomarkers Prev; 2016 Jan 15; 25(1):68-75. PubMed ID: 26512054 [Abstract] [Full Text] [Related]